Google
MGRX — MANGOCEUTICALS, INC. COMMON STOCK (Healthcare >> Health Information Services)
MGRX FAQ
What is MGRX's ROE?
MANGOCEUTICALS, INC. COMMON STOCK reports a Return on Equity (ROE) of -142.52%.
What is MGRX's dividend yield?
MANGOCEUTICALS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is MGRX's Deepscope Quality Score?
Deepscope rates MGRX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MGRX?
Deepscope's AI Timing Score for MGRX is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MGRX belong to?
MANGOCEUTICALS, INC. COMMON STOCK is classified under the Healthcare >> Health Information Services sector on the NASDAQ exchange.
|
USD 0.34
Price
-0.02
(-6.06%)
Day Change
|
|
|---|
MGRX, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 85 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.34 |
| PBV / Sector |
0.47 / 4.43
GREAT
|
| Earning Per Share | -1.03 |
| PE / Sector |
N/A / 45.31
|
| PEG or PE/Growth / Sector |
N/A / -0.25
|
| Average 1M Daily Value |
0.21 M
GREAT
|
| Average 1W Daily Value |
0.07 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-10 09:43:49 |
| Symbol | MGRX |
| Name | MANGOCEUTICALS, INC. COMMON STOCK |
| Sector | Healthcare >> Health Information Services |
| Market | NASDAQ |
| Listed Shares | 17.17 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6.35 / 3,719.35 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 17130 N. Dallas Parkway, Dallas, TX, United States, 75248
Phone: 214 242 9619
Website: https://www.mangoceuticals.com
Description: Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
ME vs SECTOR Healthcare >> Health Information Services
Click a bubble to view stock details · Bubble size represents market capitalization share
